封面
市场调查报告书
商品编码
1701969

女性健康诊断市场报告(按类型、应用、最终用户和地区)2025 年至 2033 年

Women's Health Diagnostics Market Report by Type, Application, End User, and Region 2025-2033

出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3个工作天内

价格

2024年全球女性健康诊断市场规模达311亿美元。展望未来, IMARC Group预计到2033年市场规模将达到542亿美元,2025-2033年期间的成长率(CAGR)为6.4%。市场受到以下因素的推动:被诊断患有慢性病和生活方式相关疾病的人数不断增加,诊断服务技术的重大发展,政府和公共组织透过众多活动和倡议提高对女性健康的认识,即时诊断的接受率不断提高,以及远距医疗和远距诊断行业的快速增长。

女性健康诊断有助于诊断女性患者的各种生物和社会心理状况。它们协助解决性和阴道问题以及怀孕併发症,并控制骨质疏鬆症、更年期以及乳癌和子宫颈癌等某些恶性疾病。他们依靠一系列先进的实验室测试、工具和程序,包括活检、超音波、化疗和磁振造影 (MRI)。目前,多家医疗诊断中心正在提供广泛的实验室检测解决方案,以加强对影响女性的罕见疾病和病症的诊断和管理。

女性健康诊断市场趋势:

影响女性整体健康的健康问题日益普遍,这是对市场产生正面影响的主要因素之一。此外,人们的健康意识不断增强,以及对早期诊断益处的认识不断提高,正在催化全球对即时诊断 (POC) 女性健康诊断的需求。除此之外,由于生活压力大以及酒精和药物消费量增加导致不孕不育率上升,推动了女性对健康诊断的需求,以解决妊娠併发症并确保更健康的生活。此外,由于更年期会增加某些疾病的风险,包括心血管疾病和尿失禁,50 岁以上女性人口的显着增加促进了市场的成长。除此之外,一些研究得出结论,女性在荷尔蒙变化期间更容易患上精神疾病,如忧郁和焦虑。这项措施与许多国家的卫生机构为改善女性心理健康所采取的多项措施相结合,推动了全球市场的成长。

本报告回答的关键问题

  • 2024 年全球女性健康诊断市场规模? 2025 年至 2033 年期间全球女性健康诊断市场的预期成长率为何?
  • 推动全球女性健康诊断市场发展的关键因素有哪些?
  • COVID-19 对全球女性健康诊断市场有何影响?
  • 全球女性健康诊断市场依类型分为哪些类型?
  • 根据应用,全球女性健康诊断市场是如何分布的?
  • 根据最终用户,全球女性健康诊断市场的分布如何?
  • 全球女性健康诊断市场的主要区域有哪些?
  • 全球女性健康诊断市场的主要参与者/公司有哪些?

目录

第一章:前言

第二章:范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章:执行摘要

第四章:简介

  • 概述
  • 主要行业趋势

第五章:全球女性健康诊断市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章:市场细分:依类型

  • 诊断设备
    • 关键部分
      • 切片装置
      • 影像和监控设备
      • 配件和耗材
  • 诊断测试
    • 关键部分
      • 乳癌检测
      • 子宫颈抹片检查和HPV检测
      • 怀孕测试和排卵测试
      • 其他的

第七章:市场区隔:依应用

  • 乳癌
  • 传染病检测
  • 骨质疏鬆症检测
  • 妊娠和生育能力测试
  • 性传染病检测
  • 其他的

第八章:市场区隔:按最终用户

  • 医院和诊断中心
  • 居家护理

第九章:市场细分:依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔:依国家

第十章:SWOT分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章:价值链分析

第 12 章:波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第十三章:价格分析

第 14 章:竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Becton Dickinson and Company
    • bioMerieux SA
    • Cardinal Health Inc.
    • Cook Group Incorporated
    • F. Hoffmann-La Roche AG
    • General Electric Company
    • Hologic Inc.
    • Koninklijke Philips NV
    • Perkinelmer Inc.
    • Quest Diagnostics Inc.
    • Siemens AG
    • Thermo Fisher Scientific Inc.
Product Code: SR112025A4956

The global women's health diagnostics market size reached USD 31.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 54.2 Billion by 2033, exhibiting a growth rate (CAGR) of 6.4% during 2025-2033. The market is propelled by the rising number of individuals diagnosed with chronic and lifestyle-related diseases, significant technological developments in diagnostic services, increasing awareness about women's health through numerous campaigns and initiatives by the governments and public organizations, increasing acceptance rate of point-of-care diagnostics, and rapid growth in telemedicine and remote diagnostics industry.

Women's health diagnostics help diagnose various biological and psychosocial conditions of female patients. They assist in addressing sexual and vaginal issues and pregnancy complications and managing threatening diseases, such as osteoporosis, menopause, and certain cancers like breast and cervical. They rely on a series of advanced laboratory tests, tools, and procedures, which include biopsy, ultrasound, chemotherapy, and magnetic resonance imaging (MRI). Several healthcare diagnostics centers are currently offering an expansive range of laboratory testing solutions to enhance the diagnosis and management of rare diseases and conditions that affect women.

Women's Health Diagnostics Market Trends:

The rising prevalence of health issues that impact the overall well-being of women represents one of the major factors influencing the market positively. Moreover, the growing health consciousness, along with the increasing awareness about the benefits of early diagnosis, is catalyzing the demand for point-of-care (POC) women's health diagnostics across the globe. Apart from this, the rising rate of infertility on account of stressful lifestyles and the growing consumption of alcohol and drugs is driving the need for women's health diagnostics to address pregnancy complications and ensure a healthier life. Furthermore, as menopause can increase the risk of developing certain medical conditions, including cardiovascular diseases and urinary incontinence, a significant rise in the female population which is over 50 years is contributing to the market growth. Besides this, several research studies have concluded that women are more likely to experience psychiatric disorders, such as depression and anxiety, during hormonal changes. This, in confluence with several initiatives undertaken by health agencies of numerous countries to improve mental health of women, is propelling the market growth across the globe.

Key Market Segmentation:

Breakup by Type:

  • Diagnostic Devices
  • Biopsy Device
  • Imaging and Monitoring Devices
  • Accessories and Consumables
  • Diagnostic Tests
  • Breast Cancer Testing
  • PAP Smear and HPV Test
  • Pregnancy Testing and Ovulation Testing
  • Others

Breakup by Application:

  • Breast Cancer
  • Infectious Disease Testing
  • Osteoporosis Testing
  • Pregnancy and Fertility Testing
  • Sexually Transmitted Disease Testing
  • Others

Breakup by End User:

  • Hospital and Diagnostics Centers
  • Home Care

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, bioMerieux SA, Cardinal Health Inc., Cook Group Incorporated, F. Hoffmann-La Roche AG, General Electric Company, Hologic Inc., Koninklijke Philips N.V., Perkinelmer Inc., Quest Diagnostics Inc., Siemens AG and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1.What was the size of the global women's health diagnostics market in 2024?
  • 2.What is the expected growth rate of the global women's health diagnostics market during 2025-2033?
  • 3.What are the key factors driving the global women's health diagnostics market?
  • 4.What has been the impact of COVID-19 on the global women's health diagnostics market?
  • 5.What is the breakup of the global women's health diagnostics market based on the type?
  • 6.What is the breakup of the global women's health diagnostics market based on the application?
  • 7.What is the breakup of the global women's health diagnostics market based on the end user?
  • 8.What are the key regions in the global women's health diagnostics market?
  • 9.Who are the key players/companies in the global women's health diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Women's Health Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Diagnostic Devices
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Biopsy Device
      • 6.1.2.2 Imaging and Monitoring Devices
      • 6.1.2.3 Accessories and Consumables
    • 6.1.3 Market Forecast
  • 6.2 Diagnostic Tests
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Breast Cancer Testing
      • 6.2.2.2 PAP Smear and HPV Test
      • 6.2.2.3 Pregnancy Testing and Ovulation Testing
      • 6.2.2.4 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Breast Cancer
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Infectious Disease Testing
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Osteoporosis Testing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Pregnancy and Fertility Testing
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Sexually Transmitted Disease Testing
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospital and Diagnostics Centers
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Home Care
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Becton Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 bioMerieux SA
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Cardinal Health Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Cook Group Incorporated
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 F. Hoffmann-La Roche AG
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 General Electric Company
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Hologic Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Koninklijke Philips N.V.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Perkinelmer Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Quest Diagnostics Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Siemens AG
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis
    • 14.3.13 Thermo Fisher Scientific Inc.
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Women's Health Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Women's Health Diagnostics Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Women's Health Diagnostics Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Women's Health Diagnostics Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Women's Health Diagnostics Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Women's Health Diagnostics Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Women's Health Diagnostics Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Women's Health Diagnostics (Diagnostic Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Women's Health Diagnostics (Diagnostic Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Women's Health Diagnostics (Diagnostic Tests) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Women's Health Diagnostics (Diagnostic Tests) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Women's Health Diagnostics (Breast Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Women's Health Diagnostics (Breast Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Women's Health Diagnostics (Infectious Disease Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Women's Health Diagnostics (Infectious Disease Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Women's Health Diagnostics (Osteoporosis Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Women's Health Diagnostics (Osteoporosis Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Women's Health Diagnostics (Pregnancy and Fertility Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Women's Health Diagnostics (Pregnancy and Fertility Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Women's Health Diagnostics (Sexually Transmitted Disease Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Women's Health Diagnostics (Sexually Transmitted Disease Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Women's Health Diagnostics (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Women's Health Diagnostics (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Women's Health Diagnostics (Hospital and Diagnostics Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Women's Health Diagnostics (Hospital and Diagnostics Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Women's Health Diagnostics (Home Care) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Women's Health Diagnostics (Home Care) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: North America: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: North America: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: United States: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: United States: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Canada: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Canada: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Asia-Pacific: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Asia-Pacific: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: China: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: China: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Japan: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Japan: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: India: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: India: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: South Korea: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: South Korea: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Australia: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Australia: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Indonesia: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Indonesia: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Others: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Others: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Europe: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Europe: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Germany: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Germany: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: France: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: France: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: United Kingdom: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: United Kingdom: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Italy: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Italy: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Spain: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Spain: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Russia: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Russia: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Others: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Others: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Latin America: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Latin America: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Brazil: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Brazil: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Mexico: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Mexico: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Others: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Others: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Middle East and Africa: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Middle East and Africa: Women's Health Diagnostics Market: Breakup by Country (in %), 2024
  • Figure 76: Middle East and Africa: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Global: Women's Health Diagnostics Industry: SWOT Analysis
  • Figure 78: Global: Women's Health Diagnostics Industry: Value Chain Analysis
  • Figure 79: Global: Women's Health Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Women's Health Diagnostics Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Women's Health Diagnostics Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Women's Health Diagnostics Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Women's Health Diagnostics Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Women's Health Diagnostics Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Women's Health Diagnostics Market: Competitive Structure
  • Table 7: Global: Women's Health Diagnostics Market: Key Players